169 related articles for article (PubMed ID: 11521752)
1. The potency of acyclovir can be markedly different in different cell types.
Brand G; Schiavano GF; Balestra E; Tavazzi B; Perno CF; Magnani M
Life Sci; 2001 Aug; 69(11):1285-90. PubMed ID: 11521752
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment.
Ascione C; Sala A; Mazaheri-Tehrani E; Paulone S; Palmieri B; Blasi E; Cermelli C
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):72. PubMed ID: 29137671
[TBL] [Abstract][Full Text] [Related]
3. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
4. Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir.
Rossi L; Brandi G; Schiavano GF; Balestra E; Millo E; Scarfi S; Damonte G; Gasparini A; Magnani M; Perno CF; Benatti U; De Flora A
AIDS Res Hum Retroviruses; 1998 Mar; 14(5):435-44. PubMed ID: 9546803
[TBL] [Abstract][Full Text] [Related]
5. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
[TBL] [Abstract][Full Text] [Related]
7. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of sandalwood oil against herpes simplex viruses-1 and -2.
Benencia F; Courrèges MC
Phytomedicine; 1999 May; 6(2):119-23. PubMed ID: 10374251
[TBL] [Abstract][Full Text] [Related]
10. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB
Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
12. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
14. Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
Houston DMJ; Bugert JJ; Denyer SP; Heard CM
PLoS One; 2017; 12(6):e0179291. PubMed ID: 28665969
[TBL] [Abstract][Full Text] [Related]
15. [Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
Andronova VL; Jasko MV; Kukhanova MK; Skoblov YS; Deryabin PG; Galegov GA
Vopr Virusol; 2014; 59(6):32-5. PubMed ID: 25929034
[TBL] [Abstract][Full Text] [Related]
16. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
[TBL] [Abstract][Full Text] [Related]
17. [Antiherpetic activity of 5-alkynyl derivatives of 2'-deoxyuridine].
Andronova VL; Pchelintseva AA; Ustinov AV; Petrunina AL; Korshun VA; Skorobogatyĭ MV; Galegov GA
Vopr Virusol; 2006; 51(1):34-8. PubMed ID: 16515041
[TBL] [Abstract][Full Text] [Related]
18. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
[No Abstract] [Full Text] [Related]
19. Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum.
Eo SK; Kim YS; Lee CK; Han SS
J Ethnopharmacol; 1999 Dec; 68(1-3):175-81. PubMed ID: 10624876
[TBL] [Abstract][Full Text] [Related]
20. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
Lawetz C; Liuzzi M
Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
